Adequate research funding is key to furthering developments in lung cancer treatment. Through partnering with foundations, non-profits, corporations and individual donors, the International Lung Cancer Foundation provides funding opportunities each year to facilitate advances and save lives.
Each year, the International Lung Cancer Foundation provides research funding for young and early-career investigators. This funding recognizes scientific excellence and encourages innovation in the fields of lung cancer prevention and translational medicine worldwide.
Our next Research Awards cycle begins on Monday, June 15. Check out our application site for details on the available awards and how to apply.
Go to Application Site
HYPERBOLIC: HYPER-progression Biological Outlines in advanced Lung cancer upon Immune Checkpoints blockade
Evaluating LAG3 on tumor-specific CD8+ T cells as a blood-based biomarker in NSCLC patients receiving anti-PD1 therapy
Cancer Survivors Experiencing Cancer Related Fatigue: A Phase 2 Study Evaluating A Combined Physical Activity (Pa) and Mindfulness Based Stress Reduction (Mbsr) Program: The Zenergise Trial
Towards a Better Therapeutic Ratio: The Role of Magnetic Resonance-Linear Accelerator (MR-Linac)in High-Risk Early-Stage Lung Cancer
FN14 Targeted Nanoparticles, A New Target and Treatment for Mesothelioma.
Exploiting a novel prognostic biomarker and therapeutic target to enhance chemotherapy response in non-small cell lung cancer patients.
The IASLC award has been greatly impactful in my career for a number of reasons. It allows me to learn how to use innovative and powerful technology. I chose a career in lung cancer research because lung cancer is the leading cause of cancer related deaths, a significant burden for hundreds of thousands of people and their families and because I believe that the scientific community is in the brink of major advances in the field.
The support of the IASLC has allowed me to pursue an ambitious genome sequencing project that I wouldn’t be able to fund via typical grant mechanisms at this time in my career. It is allowing our lab to launch a unique collaboration with the Women’s Health Initiative to better understand the genomic features of lung cancer in women who have never smoked.
By receiving the FMFLC/IASLC fellowship, not only was I able to make my know-how available to my colleagues and the scientific community at UCLA, but most importantly I started to connect to other scientists within my group and outside, who helped me optimize and further develop techniques, which are now state of the art in the field of molecular and cancer biology and the translational aspect of it.
The IASLC Young Investigator Award had clearly enhanced my academic career. To be the recipient of this prestigious international award has opened new doors and opportunities for me. The funding this award provided for my new scientific laboratory has been particularly helpful during my start-up phase, where it has allowed a research project on developing new treatments for SCLC to be properly resourced and to proceed ahead without hindrance.
Lung Cancer Foundation of America- Bristol-Myers Squibb/IASLC Foundation Young Investigator Research Awards in Translational Immuno-oncology The objective of the LCFA-BMC/IASLCF Young Investigator Research Awards is to support research in translational immune-oncology by early career investigators that aim to improve the care of individuals with lung cancer and to reduce the burden of these diseases. Four awards available/ $200,000 for two years. Free ME from Lung Cancer (FMFLC) and the IASLC Foundation Joint Fellowship Award The FMFLC-IASLC award is designed to fund research that will deliver a meaningful and measurable result for the early detection of lung cancer and that has a high probability of near-term benefit to lung cancer patients or individuals at risk. One award available/ $200,000 for two years.
John’s Legacy Fellowship The objective of the new IASLCF John’s Legacy Fellowship Award is to encourage that the early detection and screening of lung cancer become a standard of care in annual physicals. The fellowship was conceived by IASLCF board member, Lauren Fisher, in memory of her late husband, John Fisher. One award available/ $50,000 for one year. IASLC Foundation Fellowship and Young Investigator Awards Funding for IASLC Foundation Fellowship and Young Investigator Awards provides for the training of research fellows and young investigators who wish to pursue a career in lung cancer diagnosis, treatment, or laboratory research as well as other aspects of the study of lung tumors. Six awards available/ $50,000 for one year. Boehringer Ingelheim IASLC Foundation Chinese Research Fellowship Award Boehringer Ingelheim, in collaboration with the IASLC, have created the Chinese Lung Cancer Fellowship Award to enable a fellow to come to the United States for a one-year research project. The goal of this fellowship is to reward scientific excellence and to encourage innovative and collaborative investigation in the fields of lung cancer prevention, diagnosis and translational research with a potential impact on the management of lung cancer. One award available/ $40,000 for one year. Prevent Cancer Foundation and the IASLC Foundation Joint Research Grant The goal of this Prevent Cancer Foundation/IASLC Foundation joint grant is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. One award available/ $250,000 for one year.